Amwell® to Report Second Quarter 2024 Operating Results
Amwell® (NYSE: AMWL), a leader in hybrid care enablement, has announced it will report its second quarter 2024 operating results on Wednesday, July 31.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Amwell® (NYSE: AMWL), a leader in hybrid care enablement, has announced it will report its second quarter 2024 operating results on Wednesday, July 31. The company will host a live conference call and webcast at 5 p.m. ET on the same day to review the results and provide a general business update. Investors can access the audio webcast through the Investors section of Amwell's website or join the conference call using the provided phone numbers. A replay of the webcast will be available at investors.amwell.com for approximately 90 days after the event.
Details
News Market Reaction – AMWL
The recorded move for AMWL in the trading session of this news was -10.58%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Boston, July 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, will report its second quarter 2024 operating results on Wednesday, July 31.
Following the distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update.
The audio webcast can be accessed by visiting the Investors section of the company's website. Alternatively, participants can call (888) 510-2008 (U.S.) or (646) 960-0306 (International) to listen to the live conference call. The call ID number is 7830032.
A webcast replay of the call will be available at investors.amwell.com for approximately 90 days.
About Amwell
Amwell is a leading hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. We offer a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With nearly two decades of experience, Amwell powers the digital care of more than 50 health plans, which collectively represent more than 100 million covered lives, and many of the nation’s largest health systems. For more information, please visit https://business.amwell.com/.
©2024 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, ConvergeTM, CarepointTM and the Amwell Logo are registered trademarks or trademarks of American Well Corporation.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.